Cerep Inks Kinase-Profiling Agreement with Lilly

The agreement is an extension of an existing deal between the two companies for access to Cerep's GPCR screening portfolio.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.